Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 20:12:729193.
doi: 10.3389/fmicb.2021.729193. eCollection 2021.

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients

Affiliations

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients

Patsharaporn T Sarasombath et al. Front Microbiol. .

Abstract

Pneumocystis pneumonia (PCP) is an opportunistic infection that commonly occurs in immunocompromised individuals. A definite diagnosis of PCP can be made only when the organism is identified in a respiratory specimen. It remains unclear whether qPCR can differentiate patients with PCP from those with Pneumocystis jirovecii colonization. In this study, we retrospectively collected data from HIV and non-HIV patients during 2013-2019. A diagnosis of definite, probable PCP, or PCP excluded was made based on clinical criteria, radiological reports, and three standard laboratory staining methods with blinding to qPCR data. Data from qPCR that was performed to determine the fungal burden (DNA copies/μl) in the BAL specimens of 69 HIV and 286 non-HIV patients were then obtained and reviewed. Receiver Operating Characteristic (ROC) curve analysis was performed to determine the upper and lower cut-off values for PCP diagnosis in HIV and non-HIV groups. In the non-HIV group, the lower cut-off value of 1,480 DNA copies/μl yielded a sensitivity of 100% (95% confidence interval [CI], 91.0-100), specificity of 72.9% (95% CI, 64.0-80.7), a positive predictive value (PPV) of 54.9% (95% CI, 47.6-62.1), and a negative predictive value (NPV) of 100% with Youden index of 0.73 for PCP diagnosis. In this group, the upper cut-off value of 9,655 DNA copies/μl showed the sensitivity of 100% (95% CI, 91.0-100) and specificity of 95.8% (95% CI, 90.4-98.6) with PPV of 88.6% (95% CI, 76.8-94.8) and a NPV of 100% with Youden index of 0.96 for PCP diagnosis. Regarding the HIV group, the lower cut-off value of 1,480 DNA copies/μl showed the sensitivity of 100% (95% CI, 92.5-100%) and specificity of 91.7% (95% CI, 61.5-99.8) with PPV of 97.9% (95% CI, 87.8-99.7) and a NPV of 100% with Youden index of 0.92 for PCP diagnosis. The sensitivity and specificity of the upper cut-off value of 12,718 DNA copies/μl in this group were 97.9% (95%CI, 88.7-100) and 100% (95%CI, 73.5-100), respectively. The values above the upper cut-off point had a PPV of 100% (95% CI, N/A) and a NPV of 92.3% (95% CI, 63.3-98.8) with Youden index of 0.98 for PCP diagnosis in the HIV group.

Keywords: PCP; Pneumocystis; Pneumocystis jirovecii; Pneumocystis pneumonia; colonization; definite PCP; probable PCP; qPCR.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Scatter plot showing P. jirovecii mtLSU-rRNA DNA copies/μl in bronchoalveolar lavage (BAL) samples among definite PCP, probable PCP, and colonization in non-HIV (A) and HIV (B) groups. Each symbol represents the number of DNA recovered from each patient. The horizontal bars represent the median values with IQR. The dot lines showed the upper and lower cut-off values in HIV and non-HIV groups. Analysis was performed using the non-parametric one-way ANOVA (Kruskal-Wallis) test. ****value of p <0.0001.
Figure 2
Figure 2
Receiver Operating Characteristic (ROC) curve analysis of DNA copies/μl of BAL samples for the diagnosis of PCP in non-HIV (A) and HIV (B) groups. AUC, an area under the curve.

References

    1. Alanio A., Desoubeaux G., Sarfati C., Hamane S., Bergeron A., Azoulay E., et al. . (2011). Real-time PCR assay-based strategy for differentiation between active pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin. Microbiol. Infect. 17, 1531–1537. doi: 10.1111/j.1469-0691.2010.03400.x, PMID: - DOI - PubMed
    1. Bossart S., Mühlethaler K., Garzoni C., Furrer H. (2020). Is real time PCR preferable to the direct immunofluorescence in the diagnosis of pneumocystis jirovecii pneumonia in HIV-infected patients? BMC. Res. Notes 13:235. doi: 10.1186/s13104-020-05075-5, PMID: - DOI - PMC - PubMed
    1. Botterel F., Cabaret O., Foulet F., Cordonnier C., Costa J.-M., Bretagne S. (2012). Clinical significance of quantifying pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J. Clin. Microbiol. 50, 227–231. doi: 10.1128/JCM.06036-11, PMID: - DOI - PMC - PubMed
    1. Calderón E. J., Gutiérrez-Rivero S., Durand-Joly I., Dei-Cas E. (2010). Pneumocystis infection in humans: diagnosis and treatment. Expert Rev. Anti-Infect. Ther. 8, 683–701. doi: 10.1586/eri.10.42, PMID: - DOI - PubMed
    1. Damiani C., Le Gal S., Da Costa C., Virmaux M., Nevez G., Totet A. (2013). Combined quantification of pulmonary pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and pneumocystis colonization. J. Clin. Microbiol. 51, 3380–3388. doi: 10.1128/JCM.01554-13, PMID: - DOI - PMC - PubMed